EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseLeitlinieOpen Access · CC BY 4.0

Guidelines for Seizure Prophylaxis in Patients Undergoing Supratentorial Neurosurgery: A Statement for Healthcare Professionals from the Neurocritical Care Society

A Shaun Rowe iD, Jamie Ullman, Emily L Johnson, Emily J Gilmore, DaiWai Olson, Appaji Rayi, Eljim Tesoro, Yuhong Yuan, Sahar Zafar, Jennifer A Frontera

Neurocritical Care · 2026-08 · 45 (1) · 34-57

DOI: 10.1007/s12028-026-02522-2 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Neurocritical Care, online erschienen am 05.05.2026. Verfasst von A Shaun Rowe und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Translational Science, University of Tennessee Health Science Center College of Pharmacy, Knoxville, Tennessee, U…. Hauptthemen laut MEDLINE: Anticonvulsants, Seizures, Craniotomy, Postoperative Complications. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is significant heterogeneity related to the use of prophylactic antiseizure medications (ASM) following supratentorial craniotomy.

Methods

We conducted a systematic review and meta-analysis assessing ASM primary prophylaxis in adults hospitalized following supratentorial neurosurgery with no prior seizure history. The following population, intervention, comparator, and outcome (PICO) questions were assessed: (1) Should ASM versus no ASM be used as seizure prophylaxis in adult patients undergoing supratentorial neurosurgery? (2) If an ASM is used, should levetiracetam (LEV) or phenytoin/fosphenytoin (PHT) be preferentially used? and (3) Should a long (> 7 days) versus short (≤ 7 days) duration of prophylaxis be used? The main outcomes were early seizure (≤ 14 days), late seizures (> 14 days), adverse events, mortality, and functional and cognitive outcomes. We utilized Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology to generate recommendations.

Results

The initial literature search yielded 1988 articles, and 16 formed the basis of the recommendations. PICO 1: while meta-analysis of randomized controlled trials (RCTs) demonstrated a significant benefit for early seizure prevention, meta-analyses including all study designs was nonsignificant. Further, there were no differences in late seizure or mortality rates, and there was a trend toward higher adverse event rates with ASM. PICO 2: LEV was associated with significantly lower early seizure rates than PHT, and there were trends toward fewer late seizures and adverse events with LEV. PICO 3: only three studies examined the duration of ASM treatment, and there was no significant difference in seizure events between subjects treated for a short versus long duration.

Conclusions

We suggest that either prophylactic ASM or no ASM be used for seizure prophylaxis in patients undergoing supratentorial neurosurgery ( conditional recommendation, low quality of evidence ). If an ASM is used, we suggest LEV over PHT ( conditional recommendation, very low quality of evidence ) for a short duration ( conditional recommendation, very low quality of evidence ) .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsSeizuresCraniotomyPostoperative ComplicationsCritical CareNeurosurgical ProceduresHumansLevetiracetamPhenytoin

Stichwörter der Autor:innen

Anti-seizure medicationCraniotomyLevetiracetamPhenytoinProphylaxisSeizureSupratentorial surgery

Substanzen

AnticonvulsantsLevetiracetamPhenytoin

Autor:innen und Institutionen

  • Department of Clinical Pharmacy and Translational Science, University of Tennessee Health Science Center College of Pharmacy, Knoxville, Tennessee, USA. arowe@uthsc.edu.
  • Department of Neurosurgery, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NewYork, USA.
  • Department of Neurology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Department of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.
  • Department of Neurology, UT Southwestern, Dallas, Texas, USA.
  • Department of Neurology, Charleston Area Medical Center, Charleston, West Virginia, USA.

ORCID-Profile: A Shaun Rowe

Zitieren

APA

Rowe, A. S., Ullman, J., Johnson, E. L., Gilmore, E. J., Olson, D., Rayi, A., Tesoro, E., Yuan, Y., Zafar, S., & Frontera, J. A. (2026). Guidelines for Seizure Prophylaxis in Patients Undergoing Supratentorial Neurosurgery: A Statement for Healthcare Professionals from the Neurocritical Care Society. Neurocritical Care, 45(1), 34-57. https://doi.org/10.1007/s12028-026-02522-2

Vancouver

Rowe AS, Ullman J, Johnson EL, Gilmore EJ, Olson D, Rayi A, et al. Guidelines for Seizure Prophylaxis in Patients Undergoing Supratentorial Neurosurgery: A Statement for Healthcare Professionals from the Neurocritical Care Society. Neurocritical Care. 2026;45(1):34-57. doi:10.1007/s12028-026-02522-2

BibTeX
@article{Rowe2026,
  author = {Rowe, A Shaun and Ullman, Jamie and Johnson, Emily L and Gilmore, Emily J and Olson, DaiWai and Rayi, Appaji and Tesoro, Eljim and Yuan, Yuhong and Zafar, Sahar and Frontera, Jennifer A},
  title = {Guidelines for Seizure Prophylaxis in Patients Undergoing Supratentorial Neurosurgery: A Statement for Healthcare Professionals from the Neurocritical Care Society},
  journal = {Neurocritical Care},
  year = {2026},
  volume = {45},
  number = {1},
  pages = {34--57},
  doi = {10.1007/s12028-026-02522-2}
}
Kostenlos starten →